Prognostic Value of Delta‑like Protein 3 Combined With Thyroid Transcription Factor‑1 in Small‑cell Lung Cancer

Oncology Letters - Greece
doi 10.3892/ol.2019.10538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Activation of Insulin-Like Growth Factor 1 Receptor in Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2015English

Prognostic Value of KRAS/TP53/PIK3CA in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Prognostic Roles of Mitochondrial Transcription Termination Factors in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Prognostic Value of FDG-PET Scans at Diagnosis in Small Cell Lung Cancer

Journal of Biomedical Graphics and Computing
2013English

Predictive and Prognostic Value of 18f-Fluorodeoxyglucose Uptake Combined With Thymidylate Synthase Expression in Patients With Advanced Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2019English

Prognostic Value of Red Blood Cell Distribution Width in Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death-1 Antibody

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy